Don’t freak out about Covid-19 reinfection stories | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
July 07, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, JULY 07, 2025
Don’t freak out about Covid-19 reinfection stories

Panorama

Faye Flam, Bloomberg
10 November, 2020, 03:00 pm
Last modified: 10 November, 2020, 03:06 pm

Related News

  • New Covid-19 variant in town: Are we ready to fight the old enemy in a new guise?
  • Triple threat: Dengue, Covid cases surge as chikungunya reemerges
  • Covid-19: 2 more deaths, 4 new cases reported in 24hrs
  • Special health guidelines issued for HSC exams amid covid-19, dengue surge
  • 7 new Covid-19 cases reported in 24hrs

Don’t freak out about Covid-19 reinfection stories

All viruses operate very differently in different bodies

Faye Flam, Bloomberg
10 November, 2020, 03:00 pm
Last modified: 10 November, 2020, 03:06 pm
No two patients are the same. Photo: Bloomberg/AFP/Getty Images
No two patients are the same. Photo: Bloomberg/AFP/Getty Images

The most attention-grabbing scare stories about the pandemic often revolve around individual cases — someone who got the disease twice; a young, fit person who died; an older person who was likely infectious for more than two months. The fear is that these phenomena could be widespread, but scientists who study infectious disease say it's normal to see extreme variability in the human reaction to any virus.

Early in the pandemic, people often described the disease based on their experience or someone they knew. Some said it was just the sniffles because that's what they experienced. Others said it was worst thing that ever hit them. They're both right. But the over-generalization of these experiences can feed into the political polarization of the disease. It shouldn't. In the big picture, Covid-19 neither the Black Death or the sniffles.

"There's a vast diversity of immune responses as well as responses to infection," says Dan Barouch, a vaccine researcher at Harvard Medical School. That's the case with other pathogens from influenza to tuberculosis to HIV. "Sometimes it's because of different genetics, and sometimes it's from a different strain of the virus," he says. "In some cases, it might be due to different viral doses or other immune parameters, or demographic variables — sometimes it comes down to chance." 

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

He said he's not alarmed that there are a few documented cases of reinfection. Even if there are vastly more than the dozen or so reported reinfections, this would still represent a tiny sliver of the tens of millions of cases that have occurred worldwide.

One of the most striking examples, described in a case study in The Lancet, was a 25-year-old man in Nevada who was infected once in late March and later in May. Genetic analysis of the virus showed it was not a lingering effect of the same infection.

While other cases of reinfection were milder the second time, this one was more severe.

It's not all that surprising, says immunologist Florian Krammer of the Icahn School of Medicine at Mt. Sinai. The concentration of antibodies in different people infected with the virus follows something close to a bell curve, he says. There's a typical response, but plenty of variation out at the edges. Sometimes people with more severe infections make more antibodies, but sometimes they see sky-high antibody concentrations in people who never get symptoms.

As millions of people become infected, it's not surprising that a few get a new infection only a short time later, he says. In the Nevada case, the patient produced antibodies the second time, but possibly not the first. In another case out of Hong Kong, doctors measured a low antibody concentration after the first infection, and the patient had only a mild case the second time.

Another recent alarming case study described a 71-year-old woman with leukemia who never developed symptoms and never produced measurable antibodies, but appeared to remain infected and possibly infectious for more than 70 days — much longer than the eight days most patients are thought to be contagious.

Despite these exceptions, the experts I consulted still think most people will be immune for at least a few months after getting infected. And they expect that vaccines will work.

The immune system is complex, and offers more defenses than only antibodies. Antibodies are produced during an initial infection, says Krammer, but another component called memory B cells circulate in the body for years, retaining the ability to recognize the same virus and trigger a new immune response if it comes back.

Genes also play an intriguing role. Rheumatologist Arthur Krieg, founder of Checkmate Pharmaceuticals, says a people with a defect in a gene called TLR7 can develop particularly severe cases of Covid-19. That gene regulates an all-purpose virus fighter called interferon, which is released quickly after exposure to pathogens.

According to an article in the Journal of the American Medical Association, the TLR7 gene is on the X chromosome, and that makes the problem much more common in males. (Females have two copies of the X chromosome, so are more likely to end up with at least one normal version of the gene.) In one case described in the article, two brothers in their early 20s were sick enough to need mechanical ventilation to survive. In another, a 32-year old man and his 29-year-old brother were hospitalized, and the younger brother eventually died.

Another factor is experience with prior infections, says Krieg. There are four coronaviruses circulating in the population and causing common colds. He says exposure to these may influence the way people respond to Covid-19. Indeed, a new paper released Friday in Science shows that more than 5 percent of a sample of 302 people and more than 40 percent of a smaller group of children under 16 carried some immunity to the new coronavirus left over from these other infections. 

In a study published in September in Science, a team led by Harvard geneticist Stephen Elledge showed people who got sick enough with Covid-19 to go to the hospital were much more likely to be infected with common herpes viruses CMV and HSV-1.

These viruses are never completely cleared from the body. The researchers couldn't tell whether these other viruses are making Covid-19 worse, or whether these people are more susceptible to viruses.

While there was some early thought that severity depended on how much virus you were exposed to — the so-called viral load — the experts said that was just a hypothesis. Disease severity may be more strongly influenced by factors that determine how easily the virus grows in your body once you're infected — being exhausted or run down, for example. Environmental factors could also come into play; Krieg pointed to research led by Yale Immunologist Akiko Iwasaki showing that dry air might make the virus grow more readily in the nasal passages.

The variability in human response to the virus means there will likely be variability in the effectiveness of vaccines, he says, and that's a good reason to try to gain public trust and get everyone on board. If enough people take a vaccine, the world could achieve herd immunity, even if the vaccine only worked in, say 70% of people. But if too few people get the vaccines, then even vaccinated people might not be safe, if they're unlucky enough to be especially susceptible to the virus. And if that happens, we'll all be living with Covid-19 for a long time to come.

Disclaimer: This article first appeared on bloomberg.com, and is published by special syndication arrangement.

Analysis / Top News

Covid -19 / Reinfection

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Representational image
    Dhaka gets relief as Trump pushes tariff deadline to 1 Aug
  • Representational image. Photo: Investopedia
    GDP grows 4.86% in Jan-Mar of FY25
  • Illustration: Duniya Jahan/TBS Creative
    Inflation drops below 9% after 27 months

MOST VIEWED

  • Ships and shipping containers are pictured at the port of Long Beach in Long Beach, California, US, 30 January 2019. Photo: REUTERS
    Bangladesh may offer zero-duty on US goods to get reciprocal tariff relief
  • A quieter scene at Dhaka University’s central library on 29 June, with seats still unfilled—unlike earlier this year, when the space was overwhelmed by crowds of job aspirants preparing for competitive exams. Photo: Tahmidul Alam Jaeef
    No more long queues at DU Central Library. What changed?
  • The Mitsubishi Xpander is built with families in mind, ready to handle the daily carpool, grocery runs, weekend getaways, and everything in between. PHOTO: Akif Hamid
    Now made-in-Bangladesh: 2025 Mitsubishi Xpander
  • Illustration: Duniya Jahan/TBS Creative
    Youth believe BNP will get 39% votes, Jamaat 21%, NCP 16% in national polls: Survey
  • Labour unrests disrupt CEPZ operations as financial crisis hits factories
    Labour unrests disrupt CEPZ operations as financial crisis hits factories
  • Benapole port: Revenue exceeds target by Tk316cr while imports decline
    Benapole port: Revenue exceeds target by Tk316cr while imports decline

Related News

  • New Covid-19 variant in town: Are we ready to fight the old enemy in a new guise?
  • Triple threat: Dengue, Covid cases surge as chikungunya reemerges
  • Covid-19: 2 more deaths, 4 new cases reported in 24hrs
  • Special health guidelines issued for HSC exams amid covid-19, dengue surge
  • 7 new Covid-19 cases reported in 24hrs

Features

Thousands gather to form Bangla Blockade in mass show of support. Photo: TBS

Rebranding rebellion: Why ‘Bangla Blockade’ struck a chord

2h | Panorama
The Mitsubishi Xpander is built with families in mind, ready to handle the daily carpool, grocery runs, weekend getaways, and everything in between. PHOTO: Akif Hamid

Now made-in-Bangladesh: 2025 Mitsubishi Xpander

22h | Wheels
Students of different institutions protest demanding the reinstatement of the 2018 circular cancelling quotas in recruitment in government jobs. Photo: Mehedi Hasan

5 July 2024: Students announce class boycott amid growing protests

2d | Panorama
Contrary to long-held assumptions, Gen Z isn’t politically clueless — they understand both local and global politics well. Photo: TBS

A misreading of Gen Z’s ‘political disconnect’ set the stage for Hasina’s ouster

3d | Panorama

More Videos from TBS

Inflation drops below 9%

Inflation drops below 9%

3h | TBS Today
How much impact has Trump's tariff policy had on the market?

How much impact has Trump's tariff policy had on the market?

4h | Others
New telecom policy will prevent corruption: Faiz Ahmad Taiyeb

New telecom policy will prevent corruption: Faiz Ahmad Taiyeb

4h | TBS Today
How Anas' letter and Safwan's shirt became symbols of the July Uprising?

How Anas' letter and Safwan's shirt became symbols of the July Uprising?

1h | TBS Stories
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net